Status:
COMPLETED
Kefir Peptides for Bone Fracture Healing
Lead Sponsor:
Jen-Chieh Lai
Conditions:
Bone Fractures
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone forma...
Detailed Description
This study aims to investigate the efficacy of kefir-derived peptides in enhancing bone healing after upper limb fractures. Kefir peptides are bioactive fragments of milk proteins that have shown pote...
Eligibility Criteria
Inclusion
- (1) patients with a bone mineral density T-score determined by dual energy X-ray absorptiometry (DXA) \< -2.5 or patients with acute fragile fractures in the distal radius and proximal humerus, and additionally (2) women with menopause or (3) patients who are over 50 years of age.
Exclusion
- (1) a body mass index (BMI) \> 30, (2) those who have been administered pharmacological agents such as glucocorticoids, thyroxine, antiepileptics, bisphosphonates, calcitonin, and hormone replacement therapy, or medications impacting bone metabolism for a duration over 4 months, and (3) individuals with a documented medical history of hyperparathyroidism, hyperthyroidism, diabetes mellitus, hepatic cirrhosis, and renal insufficiency
Key Trial Info
Start Date :
April 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07166458
Start Date
April 13 2020
End Date
April 20 2025
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Chung Hsing University
Taichung, Taiwan